News Articles

Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.

Filters
Clear all
Showing 0 of 100
Keyword Search
Open Arrow
Article Type
Open Arrow
Company
Open Arrow
Clear all
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Close Icon

Algernon Pharmaceuticals Establishes 6 hours as Optimum Treatment Period for DMT in Neuron Study

News
November 1, 2021
Algernon Pharmaceuticals

Levitee Clinics and Levitee Pharmacies Provide Insight on Integrated Acquisition Strategy for its Addiction and Pain Services

News
October 28, 2021
Levitee Labs

MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder

News
October 28, 2021
MINDCURE

Cybin Announces Launch of EMBARK Psychedelic Facilitator Training Program

News
October 28, 2021
Cybin Inc.

Pasithea Therapeutics Announces Successful Treatment of First Patients in the UK with Ketamine Infusion Therapy

News
October 27, 2021
Pasithea Therapeutics

PharmaTher Provides Business Update and Releases Financial Results for the First Quarter of Fiscal 2022

News
October 27, 2021
Pharmather

Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin

News
October 27, 2021
Mydecine Innovations Group

World Leading Drug Delivery Researcher Professor Ryan Donnelly Joins PharmaTher as Scientific and Technical Advisor

News
October 27, 2021
Pharmather

Entheon Biomedical Provides Corporate Update on Studies and Clinical Trials

News
October 27, 2021
Entheon Biomedical

MINDCURE Announces Participation at Upcoming Events in November 2021

News
October 27, 2021
MINDCURE

William (Bill) J. Ciprick | CEO, Optimi Health

Spotlight
October 26, 2021
Optimi Health

Clearmind Signs Development and Supply Agreement to Produce Its Drug Candidate MEAI Psychedelic Molecule With Aragen Life Sciences

News
October 26, 2021
Clearmind Medicine

Tryp Therapeutics to Present at 15th Annual Pain Therapeutics Summit

News
October 26, 2021
Tryp Therapeutics

Numinus to Participate in Microdose Hosted Events: Psychedelic Capital and Wonderland: Miami

News
October 26, 2021
Numinus

Nova Mentis Earns Psilocybin Orphan Drug Designation in Europe for Fragile X Syndrome

News
October 26, 2021
Nova Mentis Life Science

MindMed Expands its Drug Development Pipeline with Launch of R(-)-MDMA Program

News
October 26, 2021
Mind Medicine (MindMed)

Cybin Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using Kernel Flow Technology

News
October 26, 2021
Cybin Inc.

European Patent Grant Strengthens Small Pharma’s Ketamine-Based Patent Portfolio for the Treatment of Depressive Disorders

News
October 25, 2021
Small Pharma

PsyBio Therapeutics CEO, Evan Levine, to Participate in Panel Discussion at the MedTech Innovation Conference on October 29th

News
October 25, 2021
PsyBio Therapeutics

MindMed CMO to Chair Digital Biomarkers Summit

News
October 25, 2021
Mind Medicine (MindMed)
No results found.
There are no results with this criteria. Try changing your search.
HomeNewsCompaniesSpotlightsSubscribe
Instagram
Twitter
RSS Feed
Email Us
©XXXX Psychedelic Finance. All rights reserved.
Privacy Policy
Core One Labs Inc.
Creso Pharma
Cybin Inc.
Enveric Biosciences
Field Trip Health
Filament Health
Havn Life
Levitee Labs
MINDCURE
Mydecine Innovations Group
NeonMind Biosciences Inc.
Novamind Inc.
Numinus
Optimi Health
Pharmather
PsyBio Therapeutics
Psyched Wellness
Psyence Group
Pure Extracts Corp
Silo Wellness
The Good Shroom Co
Tryp Therapeutics
Wesana Health
Aja Ventures
Albert Labs
Algernon Pharmaceuticals
Apex Labs Ltd.
B.More
Beckley Foundation
BetterLife Pharma
Bexson Biomedical
Biomind Labs
Bionomics
Braxia Scientific Corp.
Bright Minds
CB Therapeutics
Ceruvia Lifesciences
Clairvoyant Therapeutics
Clearmind Medicine
Clexio Biosciences
Cognetivity Neurosciences
Cube Psytech
Delic
Delix Therapeutics
Diamond Therapeutics
Ehave
FSD Pharma
Fluence
Freedom to Operate
HMNC Brain Health
Horizons ETFs Management Inc.
Incannex Healthcare
IntelGenx
Irwin Naturals
Ixtlan Bioscience
Johns Hopkins Medicine
MYND Diagnostics
Mind Medicine (MindMed)
MindBio Therapeutics
Mindset Pharma
Mycotopia Therapies
Mycrodose Therapeutics
Neural Therapeutics
Ninnion
Nirvana Life Sciences
Nova Mentis Life Science
Origin Therapeutics
Osmind
Pasithea Therapeutics
Pharmala Biotech Holdings
Psilera
Psilotec Health Solutions
PsyRx
Psylo
Quantified Citizen
Reunion Neuroscience
Revitalist Lifestyle and Wellness
Revive Therapeutics
Seelos Therapeutics
Small Pharma
Telescope Innovations
TheraPsil
TripSitter
Universal Ibogaine
Wellbeing Digital Sciences
Woke Pharmaceuticals
Woven Science
ATAI Life Sciences
Awakn Life Sciences
Beckley Psytech
Compass Pathways
Doseology Sciences
EI.ventures
Eleusis
Entheon Biomedical
Gilgamesh Pharmaceuticals
GoodCap Wellness
Lobe Sciences
Lophora
MAPS